[News Article]PharmAbcine' PMC-403 is featured on Pharma Tech Outlook

22 Dec 2020
PharmAbcine' PMC-403 is featured on Pharma Tech Outlook
News Article

PharmAbcine is featured on Pharma Tech Outlook, a monthly magazine that highlights breakthroughs in drug delivery system, pharmaceutical infrastructure, and tools.

The recently released Drug Discovery APAC Edition includes an exclusive article on PMC-403 from PharmAbcine, a first-in-class antibody that binds to the human Tie2 receptor.

The article introduces PMC-403’s unique mode of action and potential indications in both non-ocular and ocular pathological vessel related diseases.

Click the link below for more details.


     2F, Research Building 2, 70,

     Yuseong-daero 1689 beon-gil,
     Yuseong-gu, Daejeon, 34047, Republic of Korea

     HQ +82-42-863-2017 

     R&D Center +82-42-861-2017

     Investor Relations +70-4294-6097 

     FAX +82-42-863-2080 

     COPYRIGHT BY PharmAbcine Inc.